Tag: pharmaceutical news
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
FDA Approves Utebzi for Complicated Urinary Tract Infections
GSK plc and Spero Therapeutics announced that the US Food and Drug Administration (FDA) has approved Utebzi(tebipenem pivoxil). It is indicated for adult patients with complicated urinary tract...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
The FDA has outlined its updated strategy for generic drug oversight
The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual focus on enforcing rigorous quality standards...
Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore
Anupam Rasayan India the Gujarat based Specialty chemicals maker is all set to acquire 43.3 % stake in pharmaceutical formulations company Bliss GVS Pharma Ltd. According to reports Anupam Rasayan has already signed an agreement...
